30
/it/
AIzaSyAYiBZKx7MnpbEhh9jyipgxe19OcubqV5w
April 1, 2024
5819784
551854
1

29 sett 2020 anni - Regeneron’s monoclonal antibody treatment shows positive results in a Phase I/II/III trial. The cocktail is a mixture of 2 monoclonal antibodies: REGN10933 and REGN10987).

Aggiunto al nastro di tempo:

Data:

29 sett 2020 anni
Adesso
~ 3 years and 7 months ago